| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.1M | +0.3% | -9.0% |
| Cost of Revenue | $4.6M | -10.3% | -9.5% |
| R&D Expense | $2.9M | -8.3% | -39.8% |
| SG&A Expense | $7.0M | +7.0% | -7.9% |
| Operating Income | -$4.5M | -254.7% | -815.6% |
| Interest Expense | $614K | -0.8% | -18.7% |
| Pre-tax Income | -$5.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.3M | -17.5% | +10.8% |
| Accounts Receivable | $16.1M | -9.2% | -18.1% |
| Current Assets | $23.9M | -7.1% | -8.0% |
| Total Assets | $192.5M | -6.1% | -12.3% |
| Current Liabilities | $55.9M | -9.6% | -10.7% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $13.9M | — | — |
| Capital Expenditures | $5.8M | — | — |
| Investing Cash Flow | -$7.2M | — | — |
| Financing Cash Flow | -$8.1M | — | — |
| Free Cash Flow | $8.1M | — | — |
| -162.4% |
| -4701.0% |
| Income Tax | -$772K | +28.5% | -912.6% |
| Net Income | -$4.3M | -407.6% | -2034.5% |
| EPS (Basic) | -$0.10 | -400.0% | — |
| EPS (Diluted) | -$0.10 | -400.0% | — |
| $30.0M |
| +0.0% |
| -6.3% |
| Total Liabilities | $95.2M | -7.1% | -11.9% |
| Stockholders' Equity | $97.3M | -5.1% | -12.6% |